James Porter Email

CEO . Nuvalent

Current Roles

Employees:
134
Revenue:
$7.8M
About
Nuvalent is creating precisely targeted therapies for patients with cancer designed to overcome the limitations of existing therapies for clinically proven kinase targets. Leveraging deep expertise in structure-based design, Nuvalent develops innovative small molecules with exquisite target selectivity to overcome resistance, minimize adverse events, and drive more durable responses. Nuvalent is advancing a robust pipeline with parallel lead programs in ROS1-positive and ALK-positive NSCLC, along with multiple discovery-stage research programs. To learn more, visit www.nuvalent.com.
Nuvalent Address
One Broadway
Cambridge, MA
United States
Nuvalent Email

Past Companies

Nuvalent, Inc.CEO
VerastemProduct Development
Infinity PharmaceuticalsVP Product Development

#1 Startup Dataset

Growth rates, revenue data, direct competitors and contact details.